American Oncology Network, Inc.
AONC
$4.80
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 27.00% | 20.01% | 12.45% | 11.23% | 14.34% |
| Total Other Revenue | 13.97% | 11.94% | 17.64% | 14.72% | 16.57% |
| Total Revenue | 26.87% | 19.93% | 12.50% | 11.27% | 14.37% |
| Cost of Revenue | 30.77% | 24.79% | 17.42% | 13.51% | 13.75% |
| Gross Profit | -16.40% | -30.01% | -36.21% | -12.83% | 21.67% |
| SG&A Expenses | 35.88% | 28.30% | 17.18% | 15.88% | 4.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.16% | 25.06% | 17.40% | 13.70% | 13.02% |
| Operating Income | -665.39% | -429.04% | -323.65% | -302.62% | 223.70% |
| Income Before Tax | -266.23% | -- | -1,113.64% | -- | -52.08% |
| Income Tax Expenses | 737.78% | -- | -- | -- | 194.59% |
| Earnings from Continuing Operations | -277.06% | -- | -1,172.69% | -- | -61.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 257.92% | -- | -- | -- | -- |
| Net Income | -404.41% | -- | -314.32% | -- | 78.87% |
| EBIT | -665.39% | -429.04% | -323.65% | -302.62% | 223.70% |
| EBITDA | -320.40% | -267.59% | -220.79% | -160.84% | 2,465.89% |
| EPS Basic | -310.35% | -2,277.58% | -- | -- | -- |
| Normalized Basic EPS | 6.63% | 903.52% | -- | -- | -- |
| EPS Diluted | -355.23% | -2,488.97% | -- | -- | -- |
| Normalized Diluted EPS | -18.02% | 820.89% | -- | -- | -- |
| Average Basic Shares Outstanding | 96.98% | 145.23% | -- | -- | -- |
| Average Diluted Shares Outstanding | 226.61% | 339.72% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.80% | -- | -- | -- | -- |
